Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business

6th December 2013

Glenmark Pharmaceuticals announces the appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API business. Phil has taken charge of his responsibilities and will be based at Mahwah, NJ, USA. He will be reporting into the Chairman & Managing Director – Mr. Glenn Saldanha. In this role Phil will be responsible for the Generics and Branded business across North America as also the Global API Sales & Marketing. Phil has over 25 years of experience in the US pharmaceutical industry both in the generics and the branded space.

On his appointment, Mr. Glenn Saldanha mentions, “We believe that with Phils rich & diversified experience across the Generics & Branded Pharmaceutical businesses as well as Business Development, brings the necessary skills & acumen to lead and grow the North American operations and the API business of Glenmark.

Read source article at firstwordpharma.com


Leave a Reply

Your email address will not be published.

+ 32 = 37

« back to posts